Neuropathic Pain
📧 Sign up to get email alerts when something new happens for Neuropathic Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management [NA]
Clinical trial update on Axon Therapy for post-traumatic peripheral neuropathic pain comparing it to conventional medical management. The st…
-
FDA approval · 2024-07-11FDA Approved: PREGABALIN — Supplemental Application (ScieGen Pharmaceuticals, Inc)
FDA approved ScieGen Pharmaceuticals' generic pregabalin product through an abbreviated new drug application.
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
This clinical trial update reports safety and effectiveness results for magnetic peripheral nerve stimulation as a treatment for chemotherap…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medical Management [NA]
A completed clinical trial evaluating Axon Therapy plus conventional medical management versus sham plus conventional care for painful diabe…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Objective Assessment of Sensory Nerve Fiber Sensitivity
A completed clinical trial update assessing objective measures of sensory nerve fiber sensitivity in neuropathic pain conditions.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A Comparison Between Posterior, Lateral and Medial Approaches for Ultrasound-guided Popliteal Block [NA]
A completed clinical trial comparing posterior, lateral, and medial ultrasound-guided popliteal nerve block approaches.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Biomarkers of Neuropathic Pain in Women Treated for Breast Cancer [NA]
This is an update on a completed clinical trial investigating biomarkers of neuropathic pain in women treated for breast cancer.
-
FDA approval · 2024-06-24FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Lifestar Pharma LLC)
FDA approved a supplemental application for Amitriptyline Hydrochloride by Lifestar Pharma LLC. The submission status is AP.
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Neuroprosthetic Device for Improving Issues Caused by Diabetic Neuropathy With Specifically Designed Neural Stimulation [NA]
A clinical trial is recruiting to test a neuroprosthetic neural stimulation device aimed at improving symptoms of diabetic peripheral neurop…
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients. [Phase 1]
Phase 1 trial update for iN1011-N17 assessing safety, tolerability, and PK/PD in healthy volunteers and postherpetic neuralgia patients; rec…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers [Phase 1]
A Phase 1 single ascending dose study assessed the safety, tolerability and PK/PD of iN1011-N17 in healthy volunteers and has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) [NA]
A completed clinical trial (DISTINCT) comparing spinal cord stimulation with medical management for chronic low back pain, with results post…
-
CLINICAL_TRIALS withdrawal · 2024-06-14Clinical Trial Update: Treatment of Frostbite Sequelae With Botulinum Toxin A [Phase 2]
Phase 2 trial evaluating botulinum toxin A for frostbite sequelae has been withdrawn.
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Identifying Biomarkers and Changes in Cerebrospinal Fluid Collected Pre and Post Spinal Cord Stimulation in Subjects Suffering From Chronic Refractory Pain Conditions [NA]
Terminated clinical trial investigating cerebrospinal fluid biomarkers and biomarker changes before and after spinal cord stimulation in neu…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: TransGrade Multimodal Neuromodulation of the Dorsal Root Ganglion Ensemble for Refractory Neuropathic Pain [NA]
Clinical trial update indicates the TransGrade multimodal neuromodulation study targeting the dorsal root ganglion for refractory neuropathi…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Sham-Controlled RCT on 10kHz High-Frequency Spinal Cord Stimulation for Chronic Neuropathic Low Back Pain (Modulate-LBP) [NA]
This update reports the termination of a sham-controlled trial evaluating 10 kHz high-frequency spinal cord stimulation for chronic neuropat…
-
FDA approval · 2024-05-29FDA Approved: GABAPENTIN — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Gabapentin submitted by Amneal Pharmaceuticals LLC under ANDA202024.
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Clinical Evaluation of the Medical Device (MD) (Caloprothese Connected Kit, CCK) [NA]
Clinical trial update for the Caloprothese Connected Kit (CCK) medical device by Gregand Innovations; the study is currently recruiting to e…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Clinical Effect of LG Medipain for Managing Chronic Pain Disorders [NA]
Clinical trial update on LG Medipain for managing chronic pain disorders, including neuropathic pain, with the study currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block [NA]
This clinical trial compares sympathetic blockade using stellate ganglion block versus thoracic sympathetic ganglion block for chronic neuro…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury
A completed clinical trial examined whether untreated sleep apnea worsens secondary medical conditions after spinal cord injury, including s…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Effectiveness of Ketamine Administered by Mesotherapy in Complex Regional Pain Syndrome Type 1 (CRPS1) [Phase 2, Phase 3]
This clinical trial update reports on the effectiveness of ketamine delivered by mesotherapy for Complex Regional Pain Syndrome Type 1 in Ph…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial) [Phase 2]
A Phase 2 clinical trial is evaluating gabapentin for neuropathic pain in children and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Effects of Bodily Illusion and tDCS on SCI-related Neuropathic Pain [NA]
Clinical trial update on the effects of bodily illusion and transcranial direct current stimulation (tDCS) for SCI-related neuropathic pain …
-
FDA approval · 2024-02-26FDA Approved: GABAPENTIN — Original Application (Epic Pharma, LLC)
FDA approved the original application for gabapentin from Epic Pharma, LLC, introducing a generic gabapentin product to the market.